MICHAEL BENKOWITZ - 23 Feb 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
PRESIDENT AND COO
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
23 Feb 2026
Net transactions value
-$4,973,857
Form type
4
Filing time
24 Feb 2026, 16:31:32 UTC
Previous filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BENKOWITZ MICHAEL PRESIDENT AND COO C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 24 Feb 2026 0001673232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $1,104,000 +9,375 $117.76 9,375 23 Feb 2026 by Trust F1, F2
transaction UTHR Common Stock Sale $4,426,181 -9,375 -100% $472.13 0 23 Feb 2026 by Trust F1, F2
transaction UTHR Common Stock Options Exercise $739,642 +5,065 $146.03 5,065 23 Feb 2026 by Trust F1, F3
transaction UTHR Common Stock Sale $2,391,318 -5,065 -100% $472.13 0 23 Feb 2026 by Trust F1, F3
holding UTHR Common Stock 2,648 23 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 -9,375 -100% $0.000000 0 23 Feb 2026 Common Stock 9,375 $117.76 by Trust F1, F2
transaction UTHR Common Stock Options Exercise $0 -5,065 -100% $0.000000 0 23 Feb 2026 Common Stock 5,065 $146.03 by Trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. The transactions reported on this Form 4 are the final transactions under this trading plan.
F2 Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
F3 Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.